Peptyde Bio - About the company
Peptyde Bio is an acquired company based in St. Louis (United States), founded in 2021. It operates as a Bio platform innovating nature-positive agriculture through biological technologies for crop health. Peptyde Bio has raised $1.2M in funding from investors like QRM, St. Louis Arch Angels and BioGenerator. The company has 726 active competitors, including 76 funded and 34 that have exited. Its top competitors include companies like Kula Bio, NewLeaf Symbiotics and Fa Bio.
Company Details
Bio platform innovating nature-positive agriculture through biological technologies for crop health. The company develops biological technologies for crop health, enabling farmers to improve yields and use more natural solutions. It focuses on nature-positive solutions by combining new active ingredients with breakthrough delivery systems. The company utilizes an artificial intelligence and machine learning-enabled Discovery Engine to identify targeted biological actives for crop pests and diseases. It also deploys Biological Delivery Systems to improve the performance of actives, ensuring they reach their target and biodegrade quickly. This approach addresses sustainability concerns around traditional crop protection treatments, offering solutions for vegetables, row crops, and perennials. The company is committed to leaving every acre better for future generations, addressing consumer demands and unlocking benefits for farmers and the environment.
- Website
- peptydebio.com
- Email ID
- *****@peptydebio.com
Key Metrics
Founded Year
2021
Location
St. Louis, United States
Stage
Acquired
Total Funding
$1.2M in 1 round
Latest Funding Round
Ranked
57th among 726 active competitors
Similar Companies
Exit Details
Acquired by Invaio Tech (Dec 07, 2023)
Peptyde Bio's acquisition details
Peptyde Bio got acquired by Invaio Tech on Dec 07, 2023.
Click here to take a look at Peptyde Bio's acquisition in detail
Sign up to download Peptyde Bio's company profile
Peptyde Bio's funding and investors
Peptyde Bio has raised a total funding of $1.2M over 1 round. Its latest funding round was a Seed round on Nov 15, 2022 for $*****. 3 investors participated in its latest round. Peptyde Bio has 4 institutional investors.
Here is the list of recent funding rounds of Peptyde Bio:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 15, 2022 | 6620966 | Seed | 1753553 | 9924612 | 8605271 | 7851441 |
View details of Peptyde Bio's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Peptyde Bio's Competitors and alternates
Top competitors of Peptyde Bio include Kula Bio, NewLeaf Symbiotics and Fa Bio. Here is the list of Top 10 competitors of Peptyde Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Kula Bio 2018, Natick (United States), Series A | Manufacturer of microbial crop nutrition products | $86.7M | 68/100 | |
2nd | NewLeaf Symbiotics 2011, St. Louis (United States), Series D | Developer of biological technologies for improved crop input performance | $181M | 62/100 | |
3rd | Fa Bio 2015, Harpenden (United Kingdom), Series A | Provider of microbes for farming | $10M | 60/100 | |
4th | Manufacturer of sustainable fertilizer products designed to improve crop yields | $174M | 58/100 | ||
5th | Pivot Bio 2010, Berkeley (United States), Series D | Developer of microbial nitrogen products designed for crop nutrition enhancement | $618M | 58/100 | |
6th | SugaROx 2021, Harpenden (United Kingdom), Seed | Provider of plant sugar-based crop protection solution for farmers | $5.85M | 57/100 | |
7th | BioConsortia 2014, Davis (United States), Series E | Developer of microbial-based solutions for nitrogen fixation, disease, and nematode control | $56M | 57/100 | |
8th | Locus FS 2014, Solon (United States), Series B | Bio-based solutions enhancing performance across agriculture, industrial, mining, and oil & gas | $250M | 56/100 | |
9th | Groundwork BioAg 2014, Mazor (Israel), Series B | Developer of mycorrhizal inoculants designed to enhance crop yields and carbon sequestration | $29M | 56/100 | |
10th | Peel Pioneers 2016, Amsterdam (Netherlands), Series A | Manufacturer of ingredients extracted from citrus peels for various applications | $5.85M | 55/100 | |
57th | Peptyde Bio 2021, St. Louis (United States), Acquired | Bio platform innovating nature-positive agriculture through biological technologies for crop health | $1.2M | 36/100 |
Looking for more details on Peptyde Bio's competitors? Click here to see the top ones
Peptyde Bio's Investments and acquisitions
Peptyde Bio has made no investments or acquisitions yet.
Reports related to Peptyde Bio
Here is the latest report on Peptyde Bio's sector:
News related to Peptyde Bio
•
•
•
First Spin-Out From Donald Danforth Plant Science Center Raises Oversubscribed $1.2M Pre-Seed RoundGlobal AgInvesting•Nov 16, 2022•Peptyde Bio, Danforth Technology Company, St. Louis Arch Angels, BioGenerator and 1 other
Are you a Founder ?
FAQs about Peptyde Bio
Explore our recently published companies
- Uniqtrans.com - 2025 founded, Unfunded company
- Fuciphagus Agritech - Perai based, 2006 founded, Unfunded company
- Magellan - India based, 2020 founded, Unfunded company
- PHARMABIO Consulting - Freiburg based, 2009 founded, Unfunded company
- Francis Clase - Unfunded company
- Madewell AI - New York City based, 1937 founded, Unfunded company
